SB
Scott L Burrows (Chief Financial Officer) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Spyre Therapeutics, Inc. (SYRE). The largest single filing was $2.2M of SYRE (24,632 sh across 3 lots, as filed), executed Sep 1. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
8
0 buys · 8 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$8.8M
shares × price, as filed
Last traded
Oct 1
Filed Oct 2
Median ADV $134.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $9.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
8 filings
Sector per market data · by filing · past 12 months
Most traded names
SYRERecent filings
SYRESALE
Spyre Therapeutics, Inc.
View filing →
$300K18,428 sh × $16.26
Exec Sep 2 2025
Filed Sep 3 2025 · 5:30 PM ET